Our group explored the potential of IL‐24 to modulate components of the DDR pathway and showed that IL‐24 selectively inhibited GLI1 expression in NSCLC cells (H1299 and A549) but not in normal cells. This evidence concerns the gene IL24 and non-small cell lung carcinoma.